Loading candles…
Goldline Pharmaceutical was incorporated on August 2, 2004. The company operates in the pharmaceutical industry and markets pharmaceutical products under the 'Goldline' brand. Its business spans five segments, including pharma, wellness, and ayurvedic categories. Goldline Pharmaceutical's products are manufactured through third-party partners, following the company's specifications, market research, and quality standards. The company does not have publicly listed shares, disclosed founders, key management, subsidiaries, or specific geographic focus detailed.
This page is a live market overview for GOLDLINE PHARMACEUTICAL LIMITE (GLPL) on the BSE. As a listed security, GOLDLINE PHARMACEUTICAL LIMITE is tracked in the Healthcare segment of the Indian cash market and is widely followed for price discovery, liquidity and sector exposure. Use this overview to review price action, session ranges and derivatives context for GLPL before placing trades on tick2trade.
As of the latest feed, GLPL last traded at ₹33.15 on BSE, up ₹0 (0.00%) from the previous close of ₹33.15. Today's session range is ₹0 – ₹0, against a 52-week band of ₹0 – ₹60. Traded volume today stands at — shares.
The overview consolidates an interactive price chart with multiple time ranges, five-level bid and ask depth, upcoming corporate events for GLPL in one place so you do not need multiple screens during the session. Day and 52-week ranges help you judge whether GLPL is trading near support, resistance or the middle of its recent band. Volume and depth, when available, add context on how aggressively the name is being bought or sold.
Equity overview pages are built for investors who want a single reference for GOLDLINE PHARMACEUTICAL LIMITE before reading news, checking results or sizing a position. Corporate events and headlines in the side column surface catalysts that may explain sudden moves in GLPL. Related stocks in the same sector appear at the bottom of the page for quick peer comparison.
For a full option chain with greeks, open-interest bias, max pain and multi-leg strategy tools, open the tick2trade terminal or visit the dedicated GLPL option chain page linked from this overview.
| Type | Details | Date |
|---|---|---|
| Index Review | NSE indices rebalancing | 31 Mar 2026 |
| Expiry | Monthly F&O expiry | 30 Jan 2026 |
| Expiry | Monthly F&O expiry | 27 Feb 2026 |
| Holiday | Republic Day — market closed | 26 Jan 2026 |
Tick2trade is a brand/platform owned and operated by Besseggen InfoTech LLP, a SEBI Registered Stock Broker holding Registration No: INZ000213450, Member of NSE (Member Code: 90155) and BSE (Member Code: 6722). Investment in securities market are subject to market risks; read all related documents carefully before investing.